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CHAPTER 1 
INTRODUCTION 
 
 It is always an interesting target for scientists over decades to study on natural 
products especially on plants. Historically, plants (fruits, vegetables, medicinal herbs) 
have provided a good source of wide variety of compounds, such as phenolic 
compounds, nitrogen containing compounds, vitamins, terpenoids and some other 
secondary metabolites, which are rich in valuable bioactivities, for examples, 
antioxidant, anti-inflammatory, anti-mutagenic, anti-carcinogenic, anti-tumor anti-
bacterial, or anti-viral activities. Traditional herbal medicines have been widely used for 
thousands of years in many oriental countries such as China, Thailand and India. Herbal 
plants have recently become the main object of chemists, biochemists, and pharmacists 
(Ly et al., 2002; Juntachote et al., 2006). There is a growing shift of people choosing 
herbal cures over conventional drugs due to the perception that herbals are safer and 
have reduced side effect (Ramlan, 2003). Besides that, clinical tests using herbal 
medicine have shown no adverse effect on renal, hepatic, and bone marrow function 
(Yuan and Lin, 2000).  
Other than herbal medicine properties, natural compounds which are produced 
by plants, fungi, bacteria, protozoans, insects and animals provide us with diverse 
chemical structures. This gives us an opportunity to discover bioactive chemical 
structures to treat disease such as cancer. According to Lam (2007) and Newman et al. 
(2003), approximately 60 % of anti-cancer agents were derived from plant natural 
products and a further 20 % were natural products mimics or synthetic compounds 
derived from natural products. Hence, natural compounds from plants not only serve as 
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drugs but they also provide a rich source of novel structures that can be developed into 
novel anti-cancer agents. Most of the active compounds can be found in the wood, bark, 
stem, leaf, fruit, root, flower and seeds of many plants (Kris-Etherton et al., 2002). For 
example, vincristine from Madagascar periwinkle and taxol from the bark of the Pacific 
Yew tree. 
Cancer is one of the leading causes of death in both developed and developing 
countries and continues to be a major public health problem in many parts of world 
(Jemal et al., 2010). Epidemiologic studies have shown that cancer is caused by several 
factors such as exposure to environmental carcinogenic agents, occupational 
environment, lifestyle, nutritional habit and infectious agents (Murthy and Mathew, 
2004). Many studies and experiments have been carried out on natural sources from 
plants, marine and microorganisms to identify components which may have anti-cancer 
properties and to carry out in vivo experiments involving animals to ensure the safety. 
Resveratrol, quercetin and lycopene are examples of compounds utilized in cancer 
chemoprevention (Clinton, 1998). Existing therapies such as chemotherapy are not very 
specific for cancer cells and cause damage to normal tissue such as bone marrow, gut 
lining and hair follicles resulting in infection, diarrhea, vomiting and hair loss (Gore and 
Russell, 2003). This leads to the search for more effective and specific treatment against 
cancer.  
The systemic screening of plant for cytotoxic activity started with National 
Cancer Institute (NCI), USA in 1960. NCI had screened over 114, 000 plant extracts 
and yielded taxol and camptothecin as anti-cancer agents. Another notable large scale 
screening programmes include the work done by the Council for Scientific and 
Industrial Research (CSIR) in South Africa that identified anti-cancer agents from plant 
natural products between 1998 - 2006 (Fouche et al., 2008).  
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On this planet, the number of higher plant species (angiosperms and 
gymnosperms) are estimated at 250, 000 with lower level at 215, 000 and upper level as 
high as 50, 000 species. However, it has been estimated that only 6 % of tropical plants 
have been screened for biological activity and 15 % have been evaluated 
phytochemically (Fabricant and Farnsworth, 2001). Malaysia is listed among the 12
th
 
most biodiverse countries in the world with over 15, 000 flowering plants of which 3, 
000 species are medicinal plants. Among the medicinal plants, only about 50 are used 
commercially and even less are being researched scientifically for their medicinal 
properties (Ramlan, 2003). Alpinia, from the Zingiberaceae family, is considered a large 
and taxonomically complex genus with 230 species widely distributed throughout 
tropical and subtropical regions of Asia. Many Alpinia plants are medicinal herbs and 
have been reported to have antioxidant, anti-inflammatory, anti-cancer, 
immunostimulating, hepatoprotective and anti-nociceptive activities (Matsuda et al., 
2003).  
Alpinia scabra, locally known as ‘Lengkuas raya’, is an aromatic, perennial and 
rhizomatous herb. It is a wild species which grows largely on mountains at moderate 
elevations in Peninsular Malaysia, but it can also survive in lowlands like in the states 
of Terengganu and Northern Johor (Ibrahim et al., 2010). There is only one published 
scientific report on A. scabra (Ibrahim et al., 2010) regarding the cytotoxic activity of 
leaf and rhizome extracts of A. scabra. However, the previous report did not carry out 
detailed study to evaluate the cytotoxic and apoptotic effects of A. scabra on the human 
cancer cell lines. The experimental approach in the present study is based on bioassay-
guided fractionation. In this endeavour, the crude methanol and fractionated extracts of 
A. scabra leaves, rhizoms, roots and pseudo stems were firstly subjected to cytotoxicity 
assay in order to identify the cytotoxic extracts. After identifying the cytotoxic extracts, 
the cytotoxic active extracts were subjected to isolation and purification procedures to 
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obtain chemical constituents present in the extracts and the cytotoxic fractions were 
further tested for their cyotoxic effect and subjected to apoptosis detection. The general 
procedures in the present study are outlined in Figure 1.1.  
 
Objectives of study: 
The objectives of the present study were as follows: 
a) To evaluate the cytotoxic properties of the extracts of A. scabra 
b) To identify the bioactive fractions through bioassay guided fractionation 
technique 
c) To evaluate the cytotoxic activity of the bioactive fractions using in vitro 
cytotoxicity assay 
d) To detect the occurrence of apoptosis in treated cancer cells, namely, hormone-
dependent breast carcinoma cell line (MCF7) and ovarian cancer cell line 
(SKOV-3).  
Hypothesis of study: 
A. scabra may have the potential to be developed as cancer chemo preventive agent.  
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Figure 1.1: Outline of general procedures 
Fresh samples of A. scabra (leaves, rhizomes, roots and pseudo stems) 
Washed, dried and ground 
Dried and ground plant material 
Hexane-soluble extract  Hexane-insoluble residues 
Chloroform extract  Water extract  
 
Cytotoxic activity screenings 
Identified cytotoxic extracts 
Fractions/Sub-fractions/Identified chemical constituents 
Cytotoxic activity screenings  
- Detection of morphological changes 
- Detection of DNA fragmentation 
 
 
 
 
Extraction with methanol: water (ratio 8:2)  
 
   Extraction with hexane 
Partition with  
chloroform: water (1:1) (v/v) 
Column chromatography, TLC, 
Spectroscopic and spectrometric 
identification 
 
If active 
If active 
Crude methanol extract 
